Facebook Linkedin RSS Twitter Youtube
Home 2024

MaxCyte

Electroporation in Cell Therapy
Artificial Intelligence

Electroporation in Cell Therapy

Legend Biotech Obtains Electroporation Technology License from MaxCyte Covering Cell-Based Therapies
News

Legend Biotech Obtains Electroporation Technology License from MaxCyte Covering Cell-Based Therapies

On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthrough
GEN Edge

On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthrough

Improving Flow through the Cell Therapies Bottleneck
Bioprocessing

Improving Flow through the Cell Therapies Bottleneck

Unlocking the Potential of Electroporation for Studying Ion Channel-Related Disorders and iPSCs
Genome Editing

Unlocking the Potential of Electroporation for Studying Ion Channel-Related Disorders and iPSCs

MaxCyte Signs B Cell Platform Agreement with Walking Fish Therapeutics
Cancer

MaxCyte Signs B Cell Platform Agreement with Walking Fish Therapeutics

Manufacturing Tech Can Help Make Gene Therapies More Accessible
Bioprocessing

Manufacturing Tech Can Help Make Gene Therapies More Accessible

New Methods Improve Ab Engineering
Drug Discovery

New Methods Improve Ab Engineering

Therapeutic Antibody Discovery by Mammalian Display
Multimedia

Therapeutic Antibody Discovery by Mammalian Display

Supplement: Applications of Novel CRISPR Tools
Insights

Supplement: Applications of Novel CRISPR Tools

12Page 1 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.